Fig. 1

Survival comparison between patients with non-synonymous mutations (including all targeted genes of CAGE) and wild type carriers using an allele frequency threshold of 10%. The difference was not significant for overall survival (a), disease-free survival (b), locoregional recurrence-free survival (c), or distant metastasis-free survival (d)